📈 Stocks / Finance

Gold's growth forecast softens amid Fed and demand shifts

Yahoo Finance

The World Gold Council forecasts "much more modest growth" for gold in 2025, following a 28% surge this year driven by central bank buying. Risks include a Fed rate-cut reversal, while demand could rise if China's economy rebounds or central banks increase purchases.

Wall Street retreats as Fed rate uncertainty grows

Reuters

U.S. stocks fell, with the Nasdaq down 0.66% after hitting record highs. Producer prices rose above forecasts, while unemployment claims climbed, fueling Fed rate-cut uncertainty. Warner Bros. Discovery surged 15.4% on restructuring news, while Adobe dropped 13.7% on weak 2025 revenue guidance.

CFPB overdraft rule sparks industry backlash

CNBC

The CFPB finalized a rule limiting bank overdraft fees to $5 or cost-based levels, projected to save consumers $5 billion annually. Banks have generated $280 billion from overdrafts since 2000. The Consumer Bankers Association sued, alleging the rule overreaches and harms access to liquidity.

🪙 Crypto

BlackRock recommends modest bitcoin allocation

Reuters

BlackRock suggests investors allocate up to 2% of portfolios to bitcoin, citing diversification benefits and low correlation with major asset classes. However, it warns of bitcoin's volatility and evolving risks. Its iShares Bitcoin Trust leads with $51.1B in assets.

🌎 Global Economy

Circular economy offers a pathway to strengthen global trade

The Conversation

Research highlights the potential of a circular economy to counteract protectionist policies like tariffs. Data from the EU shows that higher national circularity rates boost trade in metals, plastics, and chemicals. Policies and innovation drive these efforts, creating economic and environmental benefits.

Pioneering medicine starts with investors like you.

Cizzle Biotech is transforming lung cancer detection with a patented, 95% accurate blood test. By joining our raise, you’ll gain ownership in a company backed by partnerships with Bio-Techne and Moffitt Cancer Center. You can build your portfolio with a stake in a medical breakthrough.

Join the Raise

^{Read the Offering information carefully before investing. It contains details of the issuer’s business, risks, charges, expenses, and other information, which should be considered before investing. Obtain a Form C and Offering Memorandum at invest.cizzlebio.com}

🗞️ Other Newsletters You Might Like

Essential stock market insights every day before the bell rings.